Support for Members Receiving Cell and Gene Therapies under the CMS CGT Access Model

This contract seeks support for members receiving cell and gene therapies specifically for sickle cell disease under the CMS Cell and Gene Therapy Access Model. The position is funded through the CGT Access Model Cooperative Agreement and is aimed at facilitating access and support for these specialized treatments. The solicitation is issued by the Mississippi Division of Medicaid and focuses on providing services within Jackson, Mississippi. The key objective is to ensure that eligible members benefit from advances in cell and gene therapy by offering targeted support as part of the broader CMS program. The solicitation reference number is 3150006693, with a response deadline of February 6, 2026. The contract falls under NAICS code 561320, indicating support services, and is categorized as a solicitation open to State and Local Entity Domestic organizations. Contact for this opportunity is Sharon Clark from the Mississippi Division of Medicaid.